AI helps discover possible therapy for rare disease

You should read the whole story:

In the seven difficult years since their son Mateo was diagnosed with a rare disease called ANDP syndrome, Victoria Malvagno and Frank Solorzano have been waiting for medicine to catch up with their lives. In 2019, the ANDP community got a breakthrough — not from a drug developer, or a doctor’s office, but from an artificial intelligence tool. The system, called mediKanren, sifted through millions of abstracts and rapidly pinpointed an unexpected target: ketamine.